SCHEMBL4959345

SCHEMBL4959345

O=C(O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.60
MAPT P10636 8/20 0.60
HTT P42858 6/20 0.60
LMNA P02545 5/20 0.60
MAPK1 P28482 1/20 0.60
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
GAA P10253 1/20 0.56
POLB P06746 1/20 0.54
RORC P51449 1/20 0.53
TP53 P04637 1/20 0.53
PKM P14618 2/20 0.51
TRPV1 Q8NER1 1/20 0.45
KCNK2 O95069 1/20 0.45
KCNK10 P57789 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959353 1.00 ALDH1A1 (0.60) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL11009493 0.89 ALDH1A1 (0.60) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL7073743 0.87 ALDH1A1 (0.58) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL9834299 0.87 ALDH1A1 (0.58) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL6811979 0.87 ALDH1A1 (0.58) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL30508352 0.87 ALDH1A1 (0.58) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL26416850 0.85 ALDH1A1 (0.67) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL9869867 0.84 ALDH1A1 (0.55) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL22734230 0.84 ALDH1A1 (0.65) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL27470288 0.84 ALDH1A1 (0.59) ALDH1A1MAPTHTTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed